Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 15/20 | 0.68 |
| ▸ | TACR3 | P29371 | 1/20 | 0.55 |
| ▸ | MITF | O75030 | 1/20 | 0.46 |
| ▸ | CCR2 | P41597 | 2/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.42 |
| ▸ | CA2 | P00918 | 2/20 | 0.42 |
| ▸ | CA4 | P22748 | 2/20 | 0.42 |
| ▸ | CA9 | Q16790 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14017628 | 1.00 | TACR1 (0.68) | TACR1TACR3MITFCCR2CA1 | |
| SCHEMBL4819222 | 1.00 | TACR1 (0.68) | TACR1TACR3MITFCCR2CA1 | |
| SCHEMBL12809390 | 0.94 | TACR1 (0.65) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL13756721 | 0.92 | TACR1 (0.62) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL14098402 | 0.92 | TACR1 (0.67) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL1400972 | 0.91 | TACR1 (0.69) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL1401249 | 0.91 | TACR1 (0.69) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL1400971 | 0.91 | TACR1 (0.69) | TACR1TACR3MITFCA1CA2 | |
| SCHEMBL1400874 | 0.89 | TACR1 (0.68) | TACR1TACR3CA1CA2CA4 | |
| SCHEMBL13980761 | 0.89 | TACR1 (0.69) | TACR1TACR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7435736-B2 | Substituted 1-piperidin-4-yl-4-azetidin-3-yl-piperazine derivatives and their use as neurokinin antagonists | JANSSEN PHARMACEUTICA, N.V. (BE) | 2008-10-14 | — | — | US | claimed |
| EP-1581517-B1 | SUBSTITUTED 1-PIPERIDIN-4-YL-4-AZETIDIN-3-YL-PIPERAZINE DERIVATIVES AND THEIR USE AS NEUROKININ ANTAGONISTS | JANSSEN PHARMACEUTICA NV (BE) | 2007-02-21 | — | — | EP | claimed |